Back
PubMed

Expanding the Utility of Exome Sequencing in Preventive and Population Genetics

Kostoulas C, Sesse A, Bouba I et al.Am J Med Genet A 2026 · May 2026
Relevance score
7/10
Disease / domain
Expanded carrier screening (ECS), 176 AR/XL disorders, preventive genetics
Source
PubMed
PMID 42212615
Share on LinkedIn

Variant / mechanism

Combined exome sequencing for ACMG/ACOG ECS (176 disorders), 276 individuals, diverse population

Summary

Exome sequencing is used for expanded carrier screening (ECS) of 176 autosomal recessive and X-linked disorders per ACMG/ACOG recommendations in 276 individuals referred for rare disorders. Carrier prevalence >1% is identified for several genes, enriching variant databases specific to the studied population. The combined approach (diagnostic exome + ECS) demonstrates economic and clinical efficiency, providing dual information on a single sample.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

The synergy between diagnostic exome and ECS in a single analysis is a pragmatic resource-optimizing approach for genetics consultation. Population-specific data from non-European populations are valuable for calibrating screening panels in geographic contexts underrepresented in large databases (gnomAD, ClinVar).

Why this score?

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 7/10

Keywords

expanded carrier screeningECSACMGexome sequencingpreventive genetics
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime